Osiris Therapeutics Articles
Osiris regains worldwide rights to Prochymal and Chondrogen from Sanofi
30 September 2012
Sanofi surprises Osiris by pulling out of Prochymal deal
13 February 2012
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
